Expression of the anti-inflammatory suppressor of cytokine signaling 3 (SOCS3) in human clear cell renal cell carcinoma

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Anja UrbschatAxel Hegele

Abstract

The oncogenic transcription factor signal transducer and activator of transcription 3 (STAT3) is a cytokine-activated transcription factor controlling inflammation, cell proliferation, survival, and differentiation in normal tissue as well as in tumor growth. One of its most important negative regulators is the suppressor of cytokine signaling 3 (SOCS3). Here, we analyzed SOCS3 and other tumor-associated local immune regulators in human clear cell renal cell carcinoma (ccRCC). Analyses were performed in tumor and adjacent tumor-free healthy renal tissue from 35 patients with ccRCC. For functional analysis, ccRCC Caki-1 cell lines were stimulated with IL-6 and IFNγ in cell culture assays. We observed significantly lower SOCS3 messenger RNA (mRNA) levels in tumor tissue compared to healthy tissue. SOCS3 mRNA strongly correlated within tumor and healthy tissue. Interestingly vice versa, SOCS3 protein levels were significantly higher in tumor tissue than in healthy tissue. IL-22 and IL-22R1 mRNA displayed no differences in tumor and healthy tissue. Stimulation of Caki-1 cells with IFNγ resulted in markedly increased SOCS3 mRNA levels. We conclude that SOCS3 along with STAT3 participates in regulatory mechanisms in ccRCC, which cert...Continue Reading

References

Jun 26, 1997·Nature·R StarrD J Hilton
Sep 12, 1997·Science·J E Darnell
Jun 3, 2000·Annual Review of Immunology·H YasukawaA Yoshimura
Feb 22, 2001·The Journal of Experimental Medicine·A SuzukiA Yoshimura
Nov 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Biao HeDavid M Jablons
May 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Carmen Gómez-GuerreroJesús Egido
May 27, 2004·International Journal of Clinical Practice·F ErdoğanO Polat
Aug 17, 2004·Immunity·Kerstin WolkRobert Sabat
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Jacques PatardAllan J Pantuck
Oct 13, 2006·Cytokine & Growth Factor Reviews·Kerstin Wolk, Robert Sabat
May 26, 2007·Nature Reviews. Immunology·Akihiko YoshimuraMasato Kubo
Jul 5, 2007·BJU International·Johanna SandlundTorgny Rasmuson
Nov 21, 2007·Nature·Catherine M KoebelRobert D Schreiber
Oct 24, 2009·Nature Reviews. Cancer·Hua YuRichard Jove
May 13, 2010·British Journal of Cancer·A HoriguchiT Asano
May 14, 2010·American Journal of Respiratory Cell and Molecular Biology·Sandra HoeglHeiko Muhl
Oct 16, 2012·European Urology·Masatoshi EtoUNKNOWN Japan Immunotherapy SNPs-Study Group for Kidney Cancer
Oct 31, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Hannes NeuwirtMichael Rudnicki
Oct 25, 2013·Nature Reviews. Cancer·Eran ElinavRichard A Flavell
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Sep 30, 2014·Journal of Cancer Research and Clinical Oncology·Guanghua LiYulong He

❮ Previous
Next ❯

Citations

Aug 10, 2016·Cytokine & Growth Factor Reviews·M Alper Kursunel, Gunes Esendagli
Jan 16, 2019·BMC Cancer·Emma Andersson EvelönnSofie Degerman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here